Cargando…

Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”

Detalles Bibliográficos
Autores principales:	Quintanal-Villalonga, A., Paz-Ares, Luis, Ferrer, Irene, Molina-Pinelo, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079511/ https://www.ncbi.nlm.nih.gov/pubmed/30116404 http://dx.doi.org/10.1155/2018/3714684

Ejemplares similares

Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications
por: Quintanal-Villalonga, A., et al.
Publicado: (2016)

Corrigendum to “Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer”
por: Marrugal, Ángela, et al.
Publicado: (2018)

Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy
por: Marrugal, Ángela, et al.
Publicado: (2023)

Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry
por: Marrugal, Ángela, et al.
Publicado: (2019)

Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma
por: Marrugal, Ángela, et al.
Publicado: (2021)

Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2018)

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
por: Ferrer, Irene, et al.
Publicado: (2018)

The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2018)

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer
por: Marrugal, Ángela, et al.
Publicado: (2016)

AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
por: Choi, Yun Jung, et al.
Publicado: (2019)

Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2017)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

Cryptotanshinone inhibits IgE-mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine-protein kinase phosphorylation in mast cells
por: Buyanravjikh, Sumiyasuren, et al.
Publicado: (2021)

Corrigendum to “Epigenetic and Neural Circuitry Landscape of Psychotherapeutic Interventions”
por: Miller, Christopher W. T.
Publicado: (2017)

Corrigendum to “Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications”
por: Wang, Shuo, et al.
Publicado: (2019)

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
por: Shroff, Rachna T, et al.
Publicado: (2018)

Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers [Corrigendum]
Publicado: (2023)

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
por: Massard, C, et al.
Publicado: (2008)

Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations
por: Hu, S, et al.
Publicado: (2017)

Corrigendum: Caenorhabditis Intervention Testing Program: the tyrosine kinase inhibitor imatinib mesylate does not extend lifespan in nematodes. microPublication Biology July 3, 2019. 10.17912/micropub.biology.000131
Publicado: (2019)

Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer [Corrigendum]
Publicado: (2017)

The affective neuroscience of socioeconomic status: implications for mental health – CORRIGENDUM
por: Hao, Yu, et al.
Publicado: (2022)

Corrigendum to “Recurrent Syncope Associated with Lung Cancer”
por: Zhang, Dingguo, et al.
Publicado: (2016)

Corrigendum to: Identifying unmet antithrombotic therapeutic need, and implications for stroke and systemic embolism in atrial fibrillation patients: a population-scale longitudinal study
Publicado: (2023)

Corrigendum to Development, Implementation, and Use of a Neurology Therapeutics Committee
Publicado: (2019)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum]
Publicado: (2021)

Corrigendum to “Myocardial Infarction in Neonates: A Diagnostic and Therapeutic Challenge”
por: Rodríguez Martínez, Manuel, et al.
Publicado: (2023)

Correction to: Fischer et al., Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
Publicado: (2018)

Corrigendum to “Chronic Immune Thrombocytopenia and Hashimoto's Hypothyroidism in an Adolescent: Presentation and Implications”
por: Ibrahim, Judy, et al.
Publicado: (2021)

Corrigendum to: Brigatinib dose rationale in anaplastic lymphoma kinase–positive non‐small cell lung cancer: Exposure–response analyses of pivotal ALTA study
Publicado: (2021)

Patient Selection for Bronchoscopic Lung Volume Reduction [Corrigendum]
Publicado: (2020)

Lung Function Assessment by Impulse Oscillometry in Adults [Corrigendum]
Publicado: (2021)

Corrigendum: The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions
por: Woodworth, Michael H, et al.
Publicado: (2019)

Corrigendum to “Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives”
por: Gitt, Stefano, et al.
Publicado: (2020)

Enhanced Efficacy of Chemically Modified Curcumin in Experimental Periodontitis: Systemic Implications [Corrigendum]
Publicado: (2020)

NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
por: Spalinger, Marianne R., et al.
Publicado: (2023)

Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
por: Godman, Brian, et al.
Publicado: (2023)

Corrigendum to “Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy”
por: Moastafa, Tarek M., et al.
Publicado: (2015)

Corrigendum to “Antidiabetic Properties, Bioactive Constituents, and Other Therapeutic Effects of Scoparia dulcis”
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2017)

Corrigendum to ‘A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)’
por: Low, Joo-Leng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gks8dk0bjsevr3b6i1b60s934h